LORI NAJAR: Open Payments
NPI 1669529129 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,652 in 174 payments from 22 companies in 2025. Trend: 2023 $1,928 · 2024 $3,176 · 2025 $4,652
Food & beverage: $3,602Consulting: $1,050
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $1,586 |
| ABBVIE INC. | 42 | $752 |
| Celltrion USA Inc. | 13 | $275 |
| Madrigal Pharmaceuticals | 11 | $260 |
| QOL Medical, LLC | 9 | $239 |
| Phathom Pharmaceuticals, Inc. | 10 | $226 |
| Aimmune Therapeutics, Inc. | 12 | $175 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $173 |
| Janssen Scientific Affairs, LLC | 1 | $145 |
| GENZYME CORPORATION | 4 | $117 |
Products named: TREMFYA, VEGZELMA, REZDIFFRA, Sucraid, DUPIXENT, VOQUEZNA, CREON, ZENPEP.
Industry payments across TX — which companies pay providers there.
